Concepedia

Serum Levels of Fetuin-A, Osteoprotegerin and Osteopontin in Patients with Coronary Artery Disease: Effects of Statin (HMGCoA-Reductase Inhibitor) Therapy

Nikolaos P. E. Kadoglou, George Kottas, Stylianos Lampropoulos, Ioulia Vitta, Christos D. Liapis

Clinical Drug Investigation · 2013 · 45 citations · 27 references

DOI

Concepts

References

27

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

New England Journal of Medicine · 1998 · 5.3K citations · Full text

, , +15

Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease

Stefan Kiechl, Georg Schett, Gregor K. Wenning et al. · Circulation · 2004 · 507 citations · Full text

, , +14

Plasma Fetuin-A Levels and the Risk of Myocardial Infarction and Ischemic Stroke

Cornelia Weikert, Norbert Stefan, Matthias B. Schulze et al. · Circulation · 2008 · 308 citations · Full text

, , +16

Osteoprotegerin and Osteopontin Are Expressed at High Concentrations Within Symptomatic Carotid Atherosclerosis

Jonathan Golledge, Moira McCann, Simone Mangan et al. · Stroke · 2004 · 223 citations · Full text

, , +13

American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey.

Helaine E. Resnick, Maureen I Harris, David Brock et al. · Diabetes Care · 2000 · 200 citations · Full text

, , +14